Turn Therapeutics (TTRX) Common Equity (2024 - 2026)
Turn Therapeutics' quarterly Common Equity came in at $6.1 million in Q1 2026, up 647.22% year-on-year from $818710.0 in Q1 2025, and up 30.53% quarter-over-quarter from $4.7 million in Q4 2025.
Turn Therapeutics has reported Common Equity for 3 years, with the latest figure at $6.1 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 647.22% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 647.22% YoY), and the FY2025 full-year result was $4.7 million, up 2741.42% from the prior year.
- Common Equity for Q1 2026 stood at $6.1 million, up from $4.7 million in the prior quarter.
- The five-year high for Common Equity was $6.1 million in Q1 2026, with the low at -$414299.0 in Q3 2024.
- Average Common Equity over 3 years is $1.9 million, with a median of $661364.5 recorded in 2025.
- Peak annual rise in Common Equity reached 2741.42% in 2025, while the deepest fall reached 221.66% in 2025.
- Tracing TTRX's Common Equity over 3 years: stood at -$177432.0 in 2024, then jumped by 2741.42% to $4.7 million in 2025, then surged by 30.53% to $6.1 million in 2026.
- The last three Common Equity figures came in at $6.1 million (Q1 2026), $4.7 million (Q4 2025), and $504019.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - | 6.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 4.69 Mn |
| Sep 30, 2025 | 504,019.00 |
| Mar 31, 2025 | 818,710.00 |
| Dec 31, 2024 | -177,432.00 |
| Sep 30, 2024 | -414,299.00 |